Publication: Natural history of PIRADS-2 lesions on serial multiparametric magnetic resonance imaging: real-life data from an academic center
| dc.contributor.coauthor | Vural, Metin | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.facultymember | Yes | |
| dc.contributor.kuauthor | Esen, Barış | |
| dc.contributor.kuauthor | Gürses, Bengi | |
| dc.contributor.kuauthor | Sekmen, Mert | |
| dc.contributor.kuauthor | Kordan, Yakup | |
| dc.contributor.kuauthor | Kiremit, Murat Can | |
| dc.contributor.kuauthor | Tilki, Derya | |
| dc.contributor.kuauthor | Esen, Tarık | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.date.accessioned | 2025-03-06T21:01:27Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Introduction/Background The natural history of prostate imaging reporting and data system (PIRADS) score 2 lesions on serial mpMRIs is largely unknown. Herein, we aimed to evaluate the patients with PIRADS-2 index lesions by using serial mpMRI scans to reveal the rates of mpMRI upgrade in PIRADS score and prostate cancer (PCa) detection. Methods/Materials All mpMRI scans with a PIRADS-2 index lesion from our mpMRI database were evaluated retrospectively. Data from 214 biopsy-naïve patients with a PIRADS-2 index lesion on the initial mpMRI who then underwent at least 1 follow-up mpMRI were reevaluated by an experienced uroradiologist and only those (n = 172) who had a PIRADS-2 index lesion on the initial mpMRI according to PIRADS v2.1 were included in the study. mpMRI progression was defined as the detection of any PIRADS ≥3 lesion at follow-up mpMRI. Histopathological results were evaluated in patients undergoing biopsy upon mpMRI progression. Results A total of 172 patients with a mean age of 60.1 ± 8.6 years were evaluated. The median PSA at baseline mpMRI was 4.7 (IQR; 3.3–6.7) ng/dl. Overall mpMRI progression was detected in 54 patients (31.4%), 37 were upgraded to PIRADS-3, 16 to PIRADS-4, and one to PIRADS-5. Multivariate logistic regression analysis revealed that a PSA increase of ≥25% during follow-up was the only predictor of mpMRI upgrade (P = 0.019, OR: 2.384). 30 out of 54 patients underwent a prostate biopsy and PCa was detected in 15 patients; 5 with ISUP grade 1, 10 with ISUP grade 2. Conclusions Almost half of the patients with a PIRADS-2 index lesion were upgraded to PIRADS ≥3 when evaluated with serial mpMRI when a PSA increase of ≥25% was observed during follow-up. PCa was detected in half of the patients who underwent a biopsy. Serial mpMRI can be recommended when monitoring patients with elevating PSA ≥25%, a prostate biopsy can be considered upon a mpMRI progression. | |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | WOS | |
| dc.description.indexedby | Scopus | |
| dc.description.indexedby | PubMed | |
| dc.description.openaccess | N/A | |
| dc.description.peerreviewstatus | N/A | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.sponsorship | BE is supported by European Urological Scholarship Programme through a 1-year research scholarship. | |
| dc.description.studentonlypublication | No | |
| dc.description.studentpublication | No | |
| dc.description.version | N/A | |
| dc.identifier.WoSQuartile | Q2 | |
| dc.identifier.doi | 10.1016/j.urolonc.2024.08.007 | |
| dc.identifier.eissn | 1873-2496 | |
| dc.identifier.embargo | N/A | |
| dc.identifier.endpage | 65.e15 | |
| dc.identifier.issn | 1078-1439 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pubmed | 39256146 | |
| dc.identifier.scopus | 2-s2.0-85203501586 | |
| dc.identifier.startpage | 65.e9 | |
| dc.identifier.uri | https://doi.org/10.1016/j.urolonc.2024.08.007 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/27988 | |
| dc.identifier.volume | 43 | |
| dc.identifier.wos | 001369860100001 | |
| dc.keywords | PSA | |
| dc.keywords | mpMRI | |
| dc.keywords | PIRADS | |
| dc.keywords | Prostate | |
| dc.keywords | Prostate cancer | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Urologic Oncology: Seminars and Original Investigations | |
| dc.relation.openaccess | N/A | |
| dc.rights | N/A | |
| dc.subject | Medicine | |
| dc.subject | Urology | |
| dc.subject | Oncology | |
| dc.title | Natural history of PIRADS-2 lesions on serial multiparametric magnetic resonance imaging: real-life data from an academic center | |
| dc.type | Journal Article | |
| dspace.entity.type | Publication | |
| local.contributor.kuauthor | Esen, Barış | |
| local.contributor.kuauthor | Gürses, Bengi | |
| local.contributor.kuauthor | Kordan, Yakup | |
| local.contributor.kuauthor | Kiremit, Murat Can | |
| local.contributor.kuauthor | Tilki, Derya | |
| local.contributor.kuauthor | Esen, Tarık | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
